Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions

Biomaterials

Volumn 32, Issue 11, 2011, Pages 2918-2929

  Alili, Lirija ^a   Sack, Maren ^a   Karakoti, Ajay S ^b   Teuber, Sarah ^a   Puschmann, Katharina ^a   Hirst, Suzanne M ^c   Reilly, Christopher M ^c   Zanger, Klaus ^a   Stahl, Wilhelm ^a   Das, Soumen ^b   Seal, Sudipta ^b   Brenneisen, Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Antioxidant; Carcinogenesis; Cell culture; Fibroblast; Nanoparticle; Tumor stroma interactions

Indexed keywords

ANTIOXIDANT; CARCINOGENESIS; CELL TOXICITY; CELL TYPES; CERIUM OXIDE NANOPARTICLE; CHEMOPREVENTION; CYTOTOXIC; CYTOTOXIC EFFECTS; MYOFIBROBLASTIC CELLS; MYOFIBROBLASTS; NANO-CERIA; PARACRINE; REACTIVE OXYGEN SPECIES; REDOX-ACTIVE; SMOOTH MUSCLE ACTINS; STROMAL CELLS; TRANSFORMING GROWTH FACTORS; TUMOR CELLS; TUMOR INVASION; TUMOR PROGRESSIONS; TUMOR-STROMA INTERACTIONS;

CERIUM; CERIUM COMPOUNDS; ENZYME INHIBITION; FIBROBLASTS; MUSCLE; NANOPARTICLES; OXYGEN; PATHOLOGY; PROTEINS; TOXICITY; TUMORS;

CELL CULTURE;

ALPHA SMOOTH MUSCLE ACTIN; CATALASE; CERIUM OXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

AGED; ARTICLE; CANCER INVASION; CHEMOPROPHYLAXIS; CHILD; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MYOFIBROBLAST; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SQUAMOUS CELL; STROMA; STROMA CELL; TUMOR; TUMOR CELL;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CATALASE; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CERIUM; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA, CONDITIONED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MYOFIBROBLASTS; NANOPARTICLES; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79951576940     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.056     Document Type: Article

References (52)

1. de Wever O., Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003, 200:429-447.
2. Liotta L.A., Kohn E.C. The microenvironment of the tumour-host interface. Nature 2001, 411:375-379.
3. Cat B., Stuhlmann D., Steinbrenner H., Alili L., Holtkötter O., Sies H., et al. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J Cell Sci 2006, 119:2727-2738.
4. Kunz-Schughart L.A., Knuechel R. Tumor-associated fibroblasts (part II): functional impact on tumor tissue. Histol Histopathol 2002, 17:623-637.
5. Desmouliere A., Guyot C., Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004, 48:509-517.
6. Cerutti P., Ghosh R., Oya Y., Amstad P. The role of the cellular antioxidant defense in oxidant carcinogenesis. Environ Health Perspect 1994, 102:123-129.
7. Freitas R.A. What is nanomedicine?. Nanomedicine 2009, 1:2-9.
8. Kuchibhatla S.V., Karakoti A.S., Bera D., Seal S. One dimensional nanostructured materials. Prog Mat Sci 2007, 52:699-913.
9. Corchero J.L., Villaverde A. Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol 2009, 27:468-476.
10. Lin W., Huang Y., Zhou X., Ma Y. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 2006, 25:451-457.
11. Karakoti A.S., Monteiro-Riviere N.A., Aggarwal R., Davis J.P., Narayan R.J., Self W.T., et al. Nanoceria as antioxidant: synthesis and biomedical applications. JOM 2008, 60:33-37.
12. Karakoti A.S., Singh S., Kumar A., Malinska M., Kuchibhatla S.V., Wozniak K., et al. PEGylated nanoceria as radical scavenger with tunable redox chemistry. J Am Chem Soc 2009, 131:14144-14145.
13. Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2009, 279:L1005-L1028.
14. Bayreuther K., Francz P.I., Gogol J., Kontermann K. Terminal differentiation, aging, apoptosis, and spontaneous transformation in fibroblast stem cell systems in vivo and in vitro. Ann N Y Acad Sci 1992, 663:167-179.
15. Boukamp P., Tilgen W., Dzarlieva R.T., Breitkreutz D., Haag D., Riehl R.K., et al. Phenotypic and genotypic characteristics of a cell line from a squamous cell carcinoma of human skin. J Natl Cancer Inst 1982, 68:415-427.
16. Stuhlmann D., Ale-Agha N., Reinehr R., Steinbrenner H., Ramos M.C., Sies H., et al. Modulation of homologous gap junctional intercellular communication of human dermal fibroblasts via a paracrine factors generated by squamous tumor cells. Carcinogenesis 2003, 24:1737-1748.
17. Karakoti A.S., Kuchibhatla S.V., Suresh Babu K., Seal S. Direct synthesis of nanoceria in aqueous polyhydroxyl solutions. J Phys Chem C 2007, 111:17232-17240.
18. Reynolds E.S. The use of lead citrate at high pH as electron opaque stain in electron microscopy. J Cell Biol 1963, 17:208-212.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
20. Speckmann B., Walter P.L., Alili L., Reinehr R., Sies H., Klotz L.O., et al. Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors. Hepatology 2008, 48:1998-2006.
21. Nishimura M., Koeda A., Suzuki E., Shimizu T., Kawano Y., Nakayama M., et al. Effects of prototypical drug-metabolizing enzyme inducers on mRNA expression of housekeeping genes in primary cultures of human and rat hepatocytes. Biochem Biophys Res Commun 2006, 346:1033-1039.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1979, 227:680-685.
23. Mauch C., Hatamochi A., Scharffetter K., Krieg T. Regulation of collagen synthesis in fibroblasts within a three-dimensional collagen gel. Exp Cell Res 1988, 178:493-503.
24. Damour O., Gueugniaud P.Y., Berthin-Maghit M., Rousselle P., Berthod F., Sahuc F., et al. A dermal substrate made of collagen-GAG-chitosan for deep burn coverage: first clinical uses. Clin Mater 1994, 15:273-276.
25. Schlotmann K., Kaeten M., Black A.F., Damour O., Waldmann-Laue M., Förster T. Cosmetic efficacy claims in vitro using a three-dimensional human skin model. Int J Cosmet Sci 2004, 23:309-318.
26. Korsvik C., Patil S., Seal S., Self W.T. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun 2007, 14:1056-1058.
27. Stuhlmann D., Steinbrenner H., Wendlandt B., Mitic D., Sies H., Brenneisen P. Paracrine effect of TGF-beta1 on downregulation of gap junctional intercellular communication between human dermal fibroblasts. Biochem Biophys Res Commun 2004, 319:321-326.
28. Heckert E.G., Seal S., Self W.T. Fenton-like reaction catalyzed by rare earth inner transition metal cerium. Environ Sci Technol 2008, 42:5014-5019.
29. Rzigalinski B.A., Meehan K., Davis R.M., Xu Y., Miles W.C., Cohen C.A. Radical nanomedicine. Nanomedicine 2006, 1:399-412.
30. Chen J., Patil S., Seal S., McGinnis J.F. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 2006, 1:142-150.
31. Schubert D., Dargusch R., Raitano J., Chan S.W. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 2006, 342:86-91.
32. Tarnuzzer R.W., Colon J., Patil S., Seal S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett 2005, 5:2573-2577.
33. Kessler D., Dethlefsen S., Haase I., Plomann M., Hirche F., Krieg T., et al. Fibroblasts in mechanically stressed collagen lattices assume a "synthetic" phenotype. J Biol Chem 2001, 276:36575-36585.
34. Arora P.D., McCulloch C.A. Dependence of collagen remodeling on alpha-smooth muscle actin expression by fibroblasts. J Cell Physiol 1994, 159:161-175.
35. Ljinen P., Petrov V., Rumilla K., Fagard R. Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblats. Methods Find. Exp Clin Pharmacol 2003, 25:79-86.
36. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Meth Enzymol 1994, 233:346-357.
37. de Wever O., Mareel M. Role of myofibroblasts at the invasion front. Biol Chem 2002, 383:55-67.
38. Heckert E.G., Karakoti A.S., Seal S., Self W.T. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 2008, 29:2705-2709.
39. Pirmohamed T., Dowding J.M., Singh S., Wasserman B., Heckert E., Karakoti A.S., et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun 2010, 46:2736-2738.
40. Perez J.M., Asati A., Nath S., Kaittanis C. Synthesis of biocompatible dextran-coated nanoceria with pH-dependent antioxidant properties. Small 2008, 4:552-556.
41. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
42. Xu J., Peng Z., Li R., Dou T., Xu W., Gu G., et al. Normoxic induction of cerebral HIF-1α by acetazolamide in rats: role of acidosis. Neurosci Lett 2009, 451:274-278.
43. Bellance N., Lestienne P., Rossignol R. Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. Front Biosci 2009, 14:4015-4034.
44. Nangaku M., Izuhara Y., Takizawa S., Yamashita T., Fujii-Kuriyama Y., Ohneda O., et al. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. Arterioscler Thromb Vasc Biol 2007, 27:2548-2554.
45. Møller P., Jacobsen N.R., Folkmann J.K., Danielsen P.H., Mikkelsen L., Hemmingsen J.G., et al. Role of oxidative damage in toxicity of particulates. Free Radic Res 2010, 44:1-46.
46. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-829.
47. Shvedova A.A., Castranova V., Kisin E.R., Schwegler-Berry D., Murray A.R., Gandelsman V.Z., et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health 2003, A66:1909-1926.
48. Auffan M., Rose J., Orsiere T., De Meo M., Thill A., Zeyons O., et al. CeO2 nanoparticles induce DNA damage towards human dermal fibroblasts in vitro. Nanotoxicology 2009, 3:161-171.
49. Brenneisen P., Briviba K., Wlaschek M., Wenk J., Scharffetter-Kochanek K. Hydrogen peroxide (H2O2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic Biol Med 1997, 22:515-524.
50. Ristow M. Oxidative metabolism in cancer growth. Curr Opin Clin Nutr Metab Care 2006, 9:339-345.
51. Zhivotovsky B., Orrenius S. The Warburg effect returns to the cancer stage. Sem Cancer Biol 2009, 19:1-3.
52. Semenza G.L. Tumor metabolism: cancer cells give and take lactate. J Clin Invest 2008, 118:3835-3837.